Log in to search using one of your social media accounts:

 

ASTRO: RT alone helps relieve dysphagia
Radiation therapy (RT) alone is as effective as radiation therapy combined (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 16, 2014 Category: Radiology Source Type: news

Cancer patients with malignant spinal cord compression have preserved mobility
(American Society for Radiation Oncology) Mobility is equally preserved in cancer patients suffering from malignant spinal cord compression who receive a single dose of 10 Gy of radiation therapy, compared to patients who receive five daily doses of 4 Gy of radiation therapy each, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 16, 2014 Category: Global & Universal Source Type: news

Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates
(American Society for Radiation Oncology) Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy have a 5-year survival rate of 40 percent, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 16, 2014 Category: Global & Universal Source Type: news

Single fraction RT as effective as multiple fraction RT for bone metastases
(American Society for Radiation Oncology) A prospective study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy is equally as effective as multiple fraction radiation therapy when pain, function and quality of life are considered, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 16, 2014 Category: Global & Universal Source Type: news

Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function
(American Society for Radiation Oncology) A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiotherapy versus combination external beam radiotherapy plus brachytherapy, indicates that the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 16, 2014 Category: Global & Universal Source Type: news

Prostate cancer patients who receive hypofractionated RT report consistent QoL
(American Society for Radiation Oncology) Prostate cancer patients who received hypofractionated radiation therapy reported that their quality of life, as well as bladder and bowel function were at similar levels before and after radiation therapy, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 16, 2014 Category: Global & Universal Source Type: news

Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer?
(Fox Chase Cancer Center) Treatment with endocrine therapy and radiation therapy as part of breast conservation is the current standard of care for women with hormone-receptor positive invasive breast cancer. A new study by researchers at Fox Chase Cancer Center, however, shows that combination may not be necessary for all patient populations with the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 16, 2014 Category: Cancer & Oncology Source Type: news

New radiosurgery technology provides highly accurate treatment, greater patient comfort
(Henry Ford Health System) A new stereotactic radiosurgery system provides the same or a higher level of accuracy in targeting cancer tumors -- but offers greater comfort to patients and the ability to treat multiple tumors at once -- when compared to other radiation therapy stereotactic systems, according to researchers at Henry Ford Hospital in Detroit. The study will be presented today, Sept. 16, at ASTRO in San Francisco. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 16, 2014 Category: Cancer & Oncology Source Type: news

ASTRO: Manuka honey no help for esophagitis pain
Don't depend on manuka honey to relieve esophagitis pain due to radiation therapy, (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 15, 2014 Category: Radiology Source Type: news

Chest Radiation May Help Fight Some Advanced Lung Cancers
Added to chemo, it lowered recurrence rates, improved survival, researchers report Source: HealthDay Related MedlinePlus Pages: Lung Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 15, 2014 Category: Consumer Health News Source Type: news

ASTRO: Rad therapy doesn't increase lymphedema risk
Patient-reported data show that radiation therapy does not increase the risk (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 15, 2014 Category: Radiology Source Type: news

Prostate cancer patients who receive hypofractionated radiation therapy report consistent quality of life before and after treatment
Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function were at similar levels before and after RT, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 15, 2014 Category: Science Source Type: news

Improved survival shown in early-stage Hodgkin's disease patients who receive radiation therapy
Patients with stage I and II Hodgkin’s Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 15, 2014 Category: Science Source Type: news

The Lancet: Some lung cancer patients could live longer when treated
(The Lancet) Treating advanced small-cell lung cancer with thoracic radiation therapy in addition to standard treatment significantly prolongs long-term survival and reduces cancer recurrence in the chest by almost 50 percent, according to new research published in The Lancet and being presented simultaneously at ASTRO's 2014 Annual Meeting in San Francisco. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2014 Category: Global & Universal Source Type: news

Advanced esophageal cancer patients who receive RT alone experience less problems when swallowing
(American Society for Radiation Oncology) Radiation therapy alone is as effective in decreasing swallowing complications experienced by advanced esophageal cancer patients as RT combined with chemotherapy, thus allowing patients to forgo chemotherapy, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2014 Category: Cancer & Oncology Source Type: news

Improved survival shown in early-stage Hodgkin's Disease patients who receive radiation therapy
(American Society for Radiation Oncology) Patients with stage I and II Hodgkin's Disease who receive consolidated radiation therapy have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2014 Category: Cancer & Oncology Source Type: news

Patient-reported data shows RT does not increase risk of lymphedema in node-negative BC patients
(American Society for Radiation Oncology) A secondary analysis of the National Surgical Adjuvant Breast and Bowel Project B-32 trial indicates that radiation therapy does not increase the incidence of lymphedema in patients with node-negative breast cancer, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2014 Category: Cancer & Oncology Source Type: news

Manuka honey does not decrease pain of radiation-induced esophagitis for lung cancer patients
(American Society for Radiation Oncology) Patient-reported data indicates that when Manuka honey is prescribed for esophagitis pain during radiation therapy, it is not more effective than standard medical care, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2014 Category: Cancer & Oncology Source Type: news

Shorter course of ADT for high-risk prostate cancer patients yields improved quality of life
(American Society for Radiation Oncology) High-risk prostate cancer patients who receive radiation therapy and an 18-month course of androgen deprivation therapy recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-month course of ADT, thus resulting in a better quality of life and without detriment to long-term outcomes, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2014 Category: Cancer & Oncology Source Type: news

Investigators from Montefiore and Einstein to present data at 2014 ASTRO Meeting
(Albert Einstein College of Medicine) Members of the Department of Radiation Oncology at Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine of Yeshiva University's NCI-designated Albert Einstein Cancer Center will present new study findings at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) revealing the impact socioeconomic status has on radiation treatment compliance, predictive indicators for clinical outcomes and on radiation therapy duration and dosing recommendations. ASTRO is being held Sept. 14 - Sept. 17 in San Francisco. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 11, 2014 Category: Global & Universal Source Type: news

RT and concurrent chemotherapy after surgery is effective treatment for high-risk endometrial cancer
(American Society for Radiation Oncology) Radiation therapy with concurrent paclitaxel chemotherapy following surgery is an effective treatment for patients with high-risk endometrial cancer, according to a study published in the Sept. 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics -- Red Journal -- the official scientific journal of the American Society for Radiation Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2014 Category: Global & Universal Source Type: news

New Data on Neoadjuvant Chemo and Breast Cancer RecurrenceNew Data on Neoadjuvant Chemo and Breast Cancer Recurrence
If breast cancer specialists could identify which patients were unlikely to experience disease recurrence after neoadjuvant chemotherapy, radiation therapy might be avoided. A new study has insights. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Rare stem cells hold potential for infertility treatments
Rare stem cells in testis that produce a biomarker protein called PAX7 help give rise to new sperm cells -- and may hold a key to restoring fertility, research suggests. Infertility, which the Centers for Disease Control estimates affects as many as 4.7 million men in the United States, is a key complication of cancer treatments, such as chemotherapy and radiation therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 4, 2014 Category: Science Source Type: news

iCAD, Volpara expand agreement
Computer-aided detection and radiation therapy firm iCAD and breast imaging (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 4, 2014 Category: Radiology Source Type: news

Breast cancer patients with bilateral mastectomy don't have better survival rates
(Stanford University Medical Center) Breast cancer patients treated with lumpectomy followed by radiation therapy survived as long as patients who had bilateral mastectomy, according to a large study conducted by researchers at the Stanford University School of Medicine and the Cancer Prevention Institute of California. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 2, 2014 Category: Cancer & Oncology Source Type: news

Doctors, patients at the crossroads make difficult decisions together
Ann Johansson/UCLA When Craig Mann was diagnosed with prostate cancer, UCLA’s novel shared decision-making program helped him, working closely with his physicians, to make the choices he felt were right for him. Craig Mann was bewildered enough when he was diagnosed with prostate cancer late last year. The 54-year-old Lake Forest, Calif., man is a laboratory scientist who takes good care of himself, eating healthy foods and participating in marathons and triathlons. He was certainly unprepared to hear that he had cancer. But the diagnosis was only the first blow. Mann was taken aback by the numerous and different tr...
Source: UCLA Newsroom: Health Sciences - August 18, 2014 Category: Universities & Medical Training Source Type: news

ASRT, Elekta announce radiation therapy scholarships
The American Society of Radiologic Technologists (ASRT) Foundation and radiation (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2014 Category: Radiology Source Type: news

Are Oncologists Recommending The Best Treatments For Patients?
Medical bias comes in many forms. For the past couple of weeks, Dr. Robert Pearl has exposed conflicts of interest in medical research and radiation therapy. This week, he sets his sights to the economic motivations behind doctors buying and reselling drugs to their patients. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 7, 2014 Category: Pharmaceuticals Authors: Robert Pearl, M.D. Source Type: news

Protein ZEB1 promotes breast tumor resistance to radiation therapy
One protein with the even more out-there name of ZEB1 (zinc finger E-box binding homeobox 1), is now thought to keep breast cancer cells from being successfully treated with radiation therapy, researchers report. ZEB1 may actually be helping breast tumor cells repair DNA damage caused by radiation treatment by ramping up a first-line of defense known as DNA damage response pathway, they say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 4, 2014 Category: Science Source Type: news

Protein ZEB1 promotes breast tumor resistance to radiation therapy
(University of Texas M. D. Anderson Cancer Center) One protein with the even more out-there name of zinc finger E-box binding homeobox 1, is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a study at The University of Texas MD Anderson Cancer Center in Houston. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news

Single-fraction RT as effective as multiple-fraction RT for palliation of bone metastases
(American Society for Radiation Oncology) Standardizing prescribing practices for single-fraction radiation therapy for palliation of bone metastases could lead to cost savings and improvement in patients' quality of life, according to a study published in the Aug. 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics, the official scientific journal of the American Society for Radiation Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news

Protein ZEB1 Promotes Breast Tumor Resistance to Radiation Therapy
One protein with the even more out-there name of  ZEB1 (zinc finger E-box binding homeobox 1), is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a study at The University of Texas MD Anderson Cancer Center in Houston. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 4, 2014 Category: Cancer & Oncology Source Type: news

American Shared Hospital Services Announces Proposed 2015 CMS Gamma Knife and Proton Therapy Reimbursement Rates
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that the Centers for Medi... Devices, Oncology, ReimbursementAmerican Shared Hospital Services, Gamma Knife, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 31, 2014 Category: Pharmaceuticals Source Type: news

Augmenix raises $11M for surgical hydrogels as Varian's purchase option expires
Varian passes on an acquisition option as Augmenix closes a Series D funding round with $10.8 million raised in support of its Space OAR hydrogel for protecting the rectum during prostate radiation therapy. Massachusetts-based Augmenix is hoping it can make it to the U.S. market with the $10.8 million funding round it just closed, the company said this month. Augmenix Inc.News Well, Funding Roundup, Radiosurgery, Surgicalread more (Source: Mass Device)
Source: Mass Device - July 28, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Two-step decision tree analysis helps inform updates of RT best practices, quality standards
(American Society for Radiation Oncology) A two-step decision tree analysis, incorporating Donabedian's model, is a feasible process to evaluate and distill the many available quality standards, guidelines, recommendations and indicators in order to update national and international quality standards for radiation therapy, according to a study published in the July-August 2014 issue of Practical Radiation Oncology, the official clinical practice journal of the American Society for Radiation Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 28, 2014 Category: Cancer & Oncology Source Type: news

AAPM: Radiomics helps fine-tune radiation therapy dose
By extracting statistical information and other measurements from PET images (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 24, 2014 Category: Radiology Source Type: news

Brainlab launches software at AAPM 2014
Brainlab said it has introduced new radiation therapy treatment planning software (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 21, 2014 Category: Radiology Source Type: news

Improving tumor radiation therapy: When basic ions break DNA down
Scientists now have a better understanding of how short DNA strands decompose in microseconds. A research team found new fragmentation pathways that occur universally when DNA strands are exposed to metal ions from a family of alkaline and alkaline earth elements. These ions tend to replace protons in the DNA backbone and at the same time induce a reactive conformation leading more readily to fragmentation. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 16, 2014 Category: Science Source Type: news

10 Non-Medical Ways to Improve Your Lung Cancer...
What if we knew of something you could do - besides surgery and chemotherapy and radiation therapy - that may improve your survival with lung cancer? Check out these tips. (Source: About.com Lung Cancer)
Source: About.com Lung Cancer - July 15, 2014 Category: Cancer & Oncology Tags: health Source Type: news

New CMS payment cuts skip imaging to focus on radiation therapy
The U.S. Centers for Medicare and Medicaid Services (CMS) has released proposed (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 8, 2014 Category: Radiology Source Type: news

Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
(Mayo Clinic) A new study by radiation oncologists at Mayo Clinic comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. The results appear in the journal Lancet Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2014 Category: Global & Universal Source Type: news

Radiation Therapy for Colon Cancer
Radiation therapy is an effective treatment for colon cancer and commonly delivered as an adjuvant therapy (complements another treatment, such as surgery). Special high-dose x-ray beams are used to kill rapidly dividing cells, like the colon cancer cells. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - July 1, 2014 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news

Proton therapy has advantages over IMRT for advanced head and neck cancers, Mayo study finds
Rochester, Minn. -- A new study by radiation oncologists at Mayo Clinic comparing the world’s literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - July 1, 2014 Category: Research Source Type: news

The Importance of Shared Decision Making During Radiation Therapy
There are quite a few different regimens today for getting the local radiation therapy that's intended to prevent local recurrence of one’s cancer. What has been learned at the University of Pennsylvania is that when a woman plays an active role i... (Source: Breast Cancer Chronicles)
Source: Breast Cancer Chronicles - June 29, 2014 Category: Consumer Health Advice Authors: Lillie Shockney Source Type: news

HIV Did Not Stop Me From Having a Biological Child
On Monday, April 15, 2013, at 8:00 a.m., my life changed forever. My wife, Kasiah, and I welcomed our first child, a healthy girl named Finley Elizabeth Banks, into this world. She was perfect. But the journey to have a healthy, HIV-free biological child began many years before Finley’s birth. MoreFederal Appeals Court Strikes Down Utah's Gay Marriage Ban NBC NewsJessica N. Turner: Moms, Put on That Swimsuit Huffington PostShould the Cops Get to Look at Your Cellphone? NBC NewsParty's Over? GOP's Insurgents Take More Punches NBC NewsUruguay eliminates Italy; Did Suarez bite again? Sports IllustratedIn 1981, when I wa...
Source: TIME.com: Top Science and Health Stories - June 25, 2014 Category: Consumer Health News Authors: clairehoworth Tags: Uncategorized AIDS research Family & Parenting Fatherhood HIV medicine Science Source Type: news

Radiation Therapy: Curative Option for RCC?Radiation Therapy: Curative Option for RCC?
Dr. Gert De Meerleer discusses the use of stereotactic body radiation therapy (SBRT) to control and potentially cure limited metastatic disease in renal cell carcinoma. Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2014 Category: Consumer Health News Tags: Hematology-Oncology Expert Interview Source Type: news

An Unused Curative Option in RCC?An Unused Curative Option in RCC?
Dr. Gert De Meerleer discusses the use of stereotactic body radiation therapy (SBRT) to control and potentially cure limited metastatic disease in renal cell carcinoma. Medscape Oncology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - June 23, 2014 Category: Urology & Nephrology Tags: Hematology-Oncology Expert Interview Source Type: news

Most prostate cancer specialists don't recommend active surveillance for low-risk patients
Specialists who treat prostate cancer agree that active surveillance is an effective option -- yet most don't recommend it when appropriate for their own patients, according to a study. Rather, urologists are more likely to recommend surgery and radiation oncologists are more likely to recommend radiation therapy -- the treatments provided by their own specialties. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 16, 2014 Category: Science Source Type: news

Proton beam therapy model policy issued
A new Model Policy for proton beam therapy (PBT) that details which cancer diagnoses meet evidence-based standards and should be covered by private insurers and Medicare has been released for use. PBT is neither a new nor an experimental technology for treating cancer with radiation. It utilizes proton radiation particles to deliver highly conformal radiation therapy to a specific tumor target area while giving a much lower dose to the normal tissues in the proton beam's path of entry and exit. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 4, 2014 Category: Science Source Type: news

Gene therapy combined with IMRT reduces rate of positive prostate biopsy after treatment for intermediate-risk prostate cancer patients
Combining oncolytic adenovirus-mediated cytotoxic gene therapy (OAMCGT) with intensity modulated radiation therapy (IMRT) reduces the risk of having a positive prostate biopsy two years after treatment in intermediate-risk prostate cancer without affecting patients’ quality of life, research has determined. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 2, 2014 Category: Science Source Type: news